The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(Hydroxymethyl)phenyl)biphenyl-4-sulfonamide ID: ALA2322484
PubChem CID: 25098358
Max Phase: Preclinical
Molecular Formula: C19H17NO3S
Molecular Weight: 339.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=S(=O)(Nc1cccc(CO)c1)c1ccc(-c2ccccc2)cc1
Standard InChI: InChI=1S/C19H17NO3S/c21-14-15-5-4-8-18(13-15)20-24(22,23)19-11-9-17(10-12-19)16-6-2-1-3-7-16/h1-13,20-21H,14H2
Standard InChI Key: QISRVSILAPJTBL-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
2.5464 -3.4600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3619 -3.4612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7688 -2.7567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3614 -2.0506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5429 -2.0534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1396 -2.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5822 -2.7544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9900 -3.4638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8064 -3.4644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2160 -2.7562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8032 -2.0461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9881 -2.0490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0332 -2.7553 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.4426 -3.4626 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0287 -1.9357 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7386 -2.3401 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2598 -3.4617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6647 -4.1692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4811 -4.1687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8898 -3.4600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4760 -2.7504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6610 -2.7544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8814 -2.0408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6985 -2.0370 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
10 13 1 0
13 14 1 0
13 15 2 0
13 16 2 0
14 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
21 23 1 0
23 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 339.42Molecular Weight (Monoisotopic): 339.0929AlogP: 3.65#Rotatable Bonds: 5Polar Surface Area: 66.40Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.84CX Basic pKa: ┄CX LogP: 3.34CX LogD: 3.22Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.75Np Likeness Score: -0.97
References 1. Greig IR, Coste E, Ralston SH, van 't Hof RJ.. (2013) Development of triarylsulfonamides as novel anti-inflammatory agents., 23 (3): [PMID:23265887 ] [10.1016/j.bmcl.2012.11.067 ]